Hancock Whitney’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.15M Buy
107,224
+6,960
+7% +$620K 0.16% 132
2025
Q4
$7.92M Sell
100,264
-30,024
-23% -$2.35M 0.14% 134
2025
Q3
$10.4M Sell
130,288
-143
-0.1% -$12.2K 0.19% 116
2025
Q2
$11.9M Buy
130,431
+95,774
+276% +$8.74M 0.23% 104
2025
Q1
$3.25M Buy
34,657
+19,073
+122% +$1.71M 0.11% 144
2024
Q4
$1.42M Buy
15,584
+3,466
+29% +$331K 0.04% 261
2024
Q3
$1.26M Buy
12,118
+277
+2% +$28.2K 0.04% 277
2024
Q2
$1.15M Sell
11,841
-176
-1% -$16.2K 0.04% 275
2024
Q1
$1.08M Buy
12,017
+151
+1% +$12.8K 0.04% 298
2023
Q4
$946K Buy
11,866
+7,853
+196% +$590K 0.04% 324
2023
Q3
$285K Sell
4,013
-997
-20% -$74.5K 0.01% 534
2023
Q2
$386K Sell
5,010
-148
-3% -$11.5K 0.02% 479
2023
Q1
$387K Sell
5,158
-10
-0.2% -$744 0.02% 484
2022
Q4
$407K Buy
5,168
+1,052
+26% +$78.9K 0.02% 469
2022
Q3
$289K Sell
4,116
-327
-7% -$25.6K 0.01% 536
2022
Q2
$356K Sell
4,443
-56
-1% -$4.38K 0.01% 500
2022
Q1
$342K Sell
4,499
-102
-2% -$8.08K 0.01% 560
2021
Q4
$392K Sell
4,601
-104
-2% -$8.12K 0.01% 527
2021
Q3
$356K Sell
4,705
-451
-9% -$35.8K 0.01% 540
2021
Q2
$419K Sell
5,156
-304
-6% -$24.9K 0.01% 603
2021
Q1
$431K Sell
5,460
-43
-0.8% -$3.37K 0.01% 582
2020
Q4
$471K Sell
5,503
-57
-1% -$4.71K 0.02% 539
2020
Q3
$429K Buy
5,560
+243
+5% +$18.5K 0.02% 542
2020
Q2
$390K Sell
5,317
-121
-2% -$8.6K 0.01% 562
2020
Q1
$360K Sell
5,438
-819
-13% -$57.8K 0.01% 579
2019
Q4
$431K Sell
6,257
-749
-11% -$51.1K 0.01% 595
2019
Q3
$516K Sell
7,006
-979
-12% -$71K 0.02% 583
2019
Q2
$572K Sell
7,985
-88
-1% -$6.25K 0.02% 588
2019
Q1
$554K Sell
8,073
-163
-2% -$10.5K 0.02% 595
2018
Q4
$491K Sell
8,236
-218
-3% -$13.6K 0.02% 584
2018
Q3
$566K Buy
8,454
+5,238
+163% +$349K 0.02% 619
2018
Q2
$209K Sell
3,216
-41
-1% -$2.68K 0.01% 532
2018
Q1
$234K Sell
3,257
-138
-4% -$9.93K 0.01% 536
2017
Q4
$256K Sell
3,395
-65
-2% -$4.75K 0.01% 511
2017
Q3
$252K Hold
3,460
0.01% 489
2017
Q2
$256K Buy
3,460
+78
+2% +$5.79K 0.01% 469
2017
Q1
$247K Sell
3,382
-211
-6% -$14.8K 0.01% 480
2016
Q4
$235K Buy
3,593
+252
+8% +$17.3K 0.01% 495
2016
Q3
$248K Buy
3,341
+341
+11% +$25.2K 0.01% 476
2016
Q2
$219K Sell
3,000
-80
-3% -$5.7K 0.01% 524
2016
Q1
$218 Sell
3,080
-600
-16% -$39.9K 0.01% 491
2015
Q4
$246K Buy
3,680
+290
+9% +$19.3K 0.01% 493
2015
Q3
$215K Buy
3,390
+280
+9% +$18.3K 0.01% 492
2015
Q2
$215K Hold
3,110
0.01% 481
2015
Q1
$215K Sell
3,110
-50
-2% -$3.46K 0.01% 481
2014
Q4
$218K Hold
3,160
0.01% 483
2014
Q3
$206K Buy
3,160
+50
+2% +$3.3K 0.01% 473
2014
Q2
$212K Hold
3,110
0.01% 480
2014
Q1
$202K Sell
3,110
-209
-6% -$13.2K 0.01% 472
2013
Q4
$216K Buy
+3,319
New +$212K 0.01% 495

Other funds holding CL

Hancock Whitney's CL Position: Q1 2026 in Review

Hancock Whitney increased its Colgate-Palmolive (CL) stake by 6.9% in Q1 2026, buying an estimated $620K and bringing the position to 107,224 shares worth $9.15M. The position accounts for 0.16% of the portfolio, ranked #132.

Hancock Whitney first reported a position in CL in Q4 2013 and has held it in 50 quarters since. The position peaked at $11.9M in Q2 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Hancock Whitney held 107,224 shares of Colgate-Palmolive worth $9.15M as of Q1 2026.
  • Hancock Whitney bought 6,960 Colgate-Palmolive shares in Q1 2026, an estimated $620K.
  • Colgate-Palmolive made up 0.16% of Hancock Whitney's portfolio in Q1 2026, its #132 holding.
  • Hancock Whitney first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 50 quarters since.
  • Hancock Whitney's Colgate-Palmolive position peaked at $11.9M in Q2 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Hancock Whitney's 13F filing for Q1 2026, filed 15 May 2026.